Showing results (91-100 of 236) with videos related to
Sort By:
Pageof 24
Rheumatology (Oxford, England)|January 9, 2025
Differences in phenotypes, treatments, and outcomes of ANCA-associated vasculitis across Europe, Japan and the USA in 2020Satoshi Omura, Takashi Kida, Andreas Kronbichler, et al.American Journal of Nephrology|September 8, 2017
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated GlomerulonephritisDuvuru Geetha, Sanjeev Sethi, An S De Vriese, et al.Annals of the Rheumatic Diseases|August 16, 2022
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remissionGabriele Gamerith, Finn Mildner, Peter A Merkel, et al.The Journal of Rheumatology|August 9, 2008
Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestationsPhilip Seo, Ulrich Specks, Karina A KeoghCurrent Rheumatology Reports|April 1, 2017
ANCA-Associated Vasculitis Pathogenesis: A CommentaryEric J Gapud, Philip Seo, Brendan AntiochosKidney International Reports|June 2, 2018
Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive HistologyTessa K Novick, Min Chen, Jennifer Scott, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 21, 2023
KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular DiseasesLaurence H Beck, Isabelle Ayoub, Dawn Caster, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2019
Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody-Associated VasculitisAndreas Kronbichler, Johannes Leierer, Jae Il Shin, et al.American Journal of Nephrology|November 26, 2018
Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody GlomerulonephritisSteven Menez, Zdenka Hruskova, Jennifer Scott, et al.American Journal of Nephrology|June 6, 2015
Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximabShivani Shah, Zdenka Hruskova, Marten Segelmark, et al.Pageof 24